Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 2105 entries
Sorted by: Best Match Show Resources per page
Comparison of soymilk and probiotic soymilk effects on serum high-density lipoprotein cholesterol and low-density lipoprotein cholesterol in diabetic Wistar rats.

ARYA atherosclerosis

Babashahi M, Mirlohi M, Ghiasvand R, Azadbakht L.
PMID: 26261455
ARYA Atheroscler. 2015 Feb;11:88-93.

BACKGROUND: Soy milk (SM) and its fermented products are identified as rich sources of bioactive compounds helping to manage and to reduce the risk of chronic disease. This study aimed to compare the effects of SM and probiotic SM...

Cite
Babashahi M, Mirlohi M, Ghiasvand R, et al. Comparison of soymilk and probiotic soymilk effects on serum high-density lipoprotein cholesterol and low-density lipoprotein cholesterol in diabetic Wistar rats. ARYA Atheroscler. 2015;11:88-93
Babashahi, M., Mirlohi, M., Ghiasvand, R., & Azadbakht, L. (2015). Comparison of soymilk and probiotic soymilk effects on serum high-density lipoprotein cholesterol and low-density lipoprotein cholesterol in diabetic Wistar rats. ARYA atherosclerosis, 1188-93.
Babashahi, Mina, et al. "Comparison of soymilk and probiotic soymilk effects on serum high-density lipoprotein cholesterol and low-density lipoprotein cholesterol in diabetic Wistar rats." ARYA atherosclerosis vol. 11 (2015): 88-93.
Babashahi M, Mirlohi M, Ghiasvand R, Azadbakht L. Comparison of soymilk and probiotic soymilk effects on serum high-density lipoprotein cholesterol and low-density lipoprotein cholesterol in diabetic Wistar rats. ARYA Atheroscler. 2015 Feb;11:88-93. PMID: 26261455; PMCID: PMC4530662.
Copy Download .nbib Format: NLM
Dissecting metabolic syndrome components: data from an epidemiologic survey in a genetic isolate.

SpringerPlus

Biino G, Concas MP, Cena H, Parracciani D, Vaccargiu S, Cosso M, Marras F, D'Esposito V, Beguinot F, Pirastu M.
PMID: 26180744
Springerplus. 2015 Jul 07;4:324. doi: 10.1186/s40064-015-1049-9. eCollection 2015.

The metabolic syndrome (MetS) is a large-scale and expanding public-health and clinical threat worldwide. We investigated the determinants of MetS, assessed its prevalence and components and, estimated their genetic contribution, taking advantage of the special characteristics of Sardinian isolated...

Cite
Biino G, Concas MP, Cena H, et al. Dissecting metabolic syndrome components: data from an epidemiologic survey in a genetic isolate. Springerplus. 2015;4:324doi: 10.1186/s40064-015-1049-9.
Biino, G., Concas, M. P., Cena, H., Parracciani, D., Vaccargiu, S., Cosso, M., Marras, F., D'Esposito, V., Beguinot, F., & Pirastu, M. (2015). Dissecting metabolic syndrome components: data from an epidemiologic survey in a genetic isolate. SpringerPlus, 4324. https://doi.org/10.1186/s40064-015-1049-9
Biino, Ginevra, et al. "Dissecting metabolic syndrome components: data from an epidemiologic survey in a genetic isolate." SpringerPlus vol. 4 (2015): 324. doi: https://doi.org/10.1186/s40064-015-1049-9
Biino G, Concas MP, Cena H, Parracciani D, Vaccargiu S, Cosso M, Marras F, D'Esposito V, Beguinot F, Pirastu M. Dissecting metabolic syndrome components: data from an epidemiologic survey in a genetic isolate. Springerplus. 2015 Jul 07;4:324. doi: 10.1186/s40064-015-1049-9. eCollection 2015. PMID: 26180744; PMCID: PMC4493262.
Copy Download .nbib Format: NLM
Safety Results of Docetaxel-(Taxotere®)-Based Chemotherapy in Early Breast Cancer Patients of Asia-Pacific Region: Asia-Pacific Breast Initiative II.

Journal of breast cancer

Kim SB, Kok YT, Thuan TV, Chao TY, Shen ZZ.
PMID: 26770242
J Breast Cancer. 2015 Dec;18(4):356-64. doi: 10.4048/jbc.2015.18.4.356. Epub 2015 Dec 23.

PURPOSE: The goal of this registry was to collect patient characteristics and safety data from patients from the Asia-Pacific region with early breast cancer receiving adjuvant chemotherapy containing docetaxel (Taxotere®).METHODS: This registry was open-label, international, longitudinal, multicenter, and observational...

Cite
Kim SB, Kok YT, Thuan TV, et al. Safety Results of Docetaxel-(Taxotere®)-Based Chemotherapy in Early Breast Cancer Patients of Asia-Pacific Region: Asia-Pacific Breast Initiative II. J Breast Cancer. 2015;18(4):356-64doi: 10.4048/jbc.2015.18.4.356.
Kim, S. B., Kok, Y. T., Thuan, T. V., Chao, T. Y., & Shen, Z. Z. (2015). Safety Results of Docetaxel-(Taxotere®)-Based Chemotherapy in Early Breast Cancer Patients of Asia-Pacific Region: Asia-Pacific Breast Initiative II. Journal of breast cancer, 18(4), 356-64. https://doi.org/10.4048/jbc.2015.18.4.356
Kim, Sung-Bae, et al. "Safety Results of Docetaxel-(Taxotere®)-Based Chemotherapy in Early Breast Cancer Patients of Asia-Pacific Region: Asia-Pacific Breast Initiative II." Journal of breast cancer vol. 18,4 (2015): 356-64. doi: https://doi.org/10.4048/jbc.2015.18.4.356
Kim SB, Kok YT, Thuan TV, Chao TY, Shen ZZ. Safety Results of Docetaxel-(Taxotere®)-Based Chemotherapy in Early Breast Cancer Patients of Asia-Pacific Region: Asia-Pacific Breast Initiative II. J Breast Cancer. 2015 Dec;18(4):356-64. doi: 10.4048/jbc.2015.18.4.356. Epub 2015 Dec 23. PMID: 26770242; PMCID: PMC4705087.
Copy Download .nbib Format: NLM
Martin's Equation as the Most Suitable Method for Estimation of Low-Density Lipoprotein Cholesterol Levels in Korean Adults.

Korean journal of family medicine

Kang M, Kim J, Lee SY, Kim K, Yoon J, Ki H.
PMID: 29026486
Korean J Fam Med. 2017 Sep;38(5):263-269. doi: 10.4082/kjfm.2017.38.5.263. Epub 2017 Sep 22.

BACKGROUND: Friedewald equation is the most widely used method for estimating low-density lipoprotein cholesterol (LDL-C) level. However, due to potential over- or underestimation, many studies have used a modified equation. This study aimed to compare estimates by 4 different...

Cite
Kang M, Kim J, Lee SY, et al. Martin's Equation as the Most Suitable Method for Estimation of Low-Density Lipoprotein Cholesterol Levels in Korean Adults. Korean J Fam Med. 2017;38(5):263-269doi: 10.4082/kjfm.2017.38.5.263.
Kang, M., Kim, J., Lee, S. Y., Kim, K., Yoon, J., & Ki, H. (2017). Martin's Equation as the Most Suitable Method for Estimation of Low-Density Lipoprotein Cholesterol Levels in Korean Adults. Korean journal of family medicine, 38(5), 263-269. https://doi.org/10.4082/kjfm.2017.38.5.263
Kang, Mijeong, et al. "Martin's Equation as the Most Suitable Method for Estimation of Low-Density Lipoprotein Cholesterol Levels in Korean Adults." Korean journal of family medicine vol. 38,5 (2017): 263-269. doi: https://doi.org/10.4082/kjfm.2017.38.5.263
Kang M, Kim J, Lee SY, Kim K, Yoon J, Ki H. Martin's Equation as the Most Suitable Method for Estimation of Low-Density Lipoprotein Cholesterol Levels in Korean Adults. Korean J Fam Med. 2017 Sep;38(5):263-269. doi: 10.4082/kjfm.2017.38.5.263. Epub 2017 Sep 22. PMID: 29026486; PMCID: PMC5637217.
Copy Download .nbib Format: NLM
Correlation of Serum Lipoprotein Ratios with Insulin Resistance in Infertile Women with Polycystic Ovarian Syndrome: A Case Control Study.

International journal of fertility & sterility

Ghaffarzad A, Amani R, Mehrzad Sadaghiani M, Darabi M, Cheraghian B.
PMID: 27123197
Int J Fertil Steril. 2016 Apr-Jun;10(1):29-35. doi: 10.22074/ijfs.2016.4765. Epub 2016 Apr 05.

BACKGROUND: Dyslipidemia and insulin resistance (IR), occurring in most infertile women with polycystic ovarian syndrome (PCOS), increase the risk of cardiovascular disease (CVD) and type 2 diabetes. This study aimed to assess the relationships between lipoprotein ratios and IR...

Cite
Ghaffarzad A, Amani R, Mehrzad Sadaghiani M, et al. Correlation of Serum Lipoprotein Ratios with Insulin Resistance in Infertile Women with Polycystic Ovarian Syndrome: A Case Control Study. Int J Fertil Steril. 2016;10(1):29-35doi: 10.22074/ijfs.2016.4765.
Ghaffarzad, A., Amani, R., Mehrzad Sadaghiani, M., Darabi, M., & Cheraghian, B. (2016). Correlation of Serum Lipoprotein Ratios with Insulin Resistance in Infertile Women with Polycystic Ovarian Syndrome: A Case Control Study. International journal of fertility & sterility, 10(1), 29-35. https://doi.org/10.22074/ijfs.2016.4765
Ghaffarzad, Aisa, et al. "Correlation of Serum Lipoprotein Ratios with Insulin Resistance in Infertile Women with Polycystic Ovarian Syndrome: A Case Control Study." International journal of fertility & sterility vol. 10,1 (2016): 29-35. doi: https://doi.org/10.22074/ijfs.2016.4765
Ghaffarzad A, Amani R, Mehrzad Sadaghiani M, Darabi M, Cheraghian B. Correlation of Serum Lipoprotein Ratios with Insulin Resistance in Infertile Women with Polycystic Ovarian Syndrome: A Case Control Study. Int J Fertil Steril. 2016 Apr-Jun;10(1):29-35. doi: 10.22074/ijfs.2016.4765. Epub 2016 Apr 05. PMID: 27123197; PMCID: PMC4845526.
Copy Download .nbib Format: NLM
High atherogenic index of plasma in subclinical hypothyroidism: Implications in assessment of cardiovascular disease risk.

Indian journal of endocrinology and metabolism

James SR, Ray L, Ravichandran K, Nanda SK.
PMID: 27730076
Indian J Endocrinol Metab. 2016 Sep-Oct;20(5):656-661. doi: 10.4103/2230-8210.190550.

BACKGROUND: A controversy exists regarding the association between subclinical hypothyroidism (SH) and dyslipidemia. Moreover, studies on lipid ratios and atherogenic index of plasma (AIP) in SH are rare, particularly in the Indian scenario.AIM: This study aimed to investigate abnormalities...

Cite
James SR, Ray L, Ravichandran K, et al. High atherogenic index of plasma in subclinical hypothyroidism: Implications in assessment of cardiovascular disease risk. Indian J Endocrinol Metab. 2016;20(5):656-661doi: 10.4103/2230-8210.190550.
James, S. R., Ray, L., Ravichandran, K., & Nanda, S. K. (2016). High atherogenic index of plasma in subclinical hypothyroidism: Implications in assessment of cardiovascular disease risk. Indian journal of endocrinology and metabolism, 20(5), 656-661. https://doi.org/10.4103/2230-8210.190550
James, Stephen R, et al. "High atherogenic index of plasma in subclinical hypothyroidism: Implications in assessment of cardiovascular disease risk." Indian journal of endocrinology and metabolism vol. 20,5 (2016): 656-661. doi: https://doi.org/10.4103/2230-8210.190550
James SR, Ray L, Ravichandran K, Nanda SK. High atherogenic index of plasma in subclinical hypothyroidism: Implications in assessment of cardiovascular disease risk. Indian J Endocrinol Metab. 2016 Sep-Oct;20(5):656-661. doi: 10.4103/2230-8210.190550. PMID: 27730076; PMCID: PMC5040046.
Copy Download .nbib Format: NLM
Impact of Vitamin D deficiency on subclinical carotid atherosclerosis: a pooled analysis of cohort studies.

The Journal of clinical endocrinology and metabolism

Lupoli R, Vaccaro A, Ambrosino P, Poggio P, Amato M, Di Minno MN.
PMID: 28609831
J Clin Endocrinol Metab. 2017 Jul;102(7):2146-2153. doi: 10.1210/jc.2017-00342. Epub 2017 May 09.

CONTEXT: Vitamin D deficiency patients have an increased cardiovascular (CV) morbidity and mortality. Carotid intima-media thickness (IMT) and carotid plaques are markers of subclinical atherosclerosis and predictors of CV events.OBJECTIVE: To perform a meta-analysis of studies evaluating the impact...

Cite
Lupoli R, Vaccaro A, Ambrosino P, et al. Impact of Vitamin D deficiency on subclinical carotid atherosclerosis: a pooled analysis of cohort studies. J Clin Endocrinol Metab. 2017;102(7):2146-2153doi: 10.1210/jc.2017-00342.
Lupoli, R., Vaccaro, A., Ambrosino, P., Poggio, P., Amato, M., & Di Minno, M. N. (2017). Impact of Vitamin D deficiency on subclinical carotid atherosclerosis: a pooled analysis of cohort studies. The Journal of clinical endocrinology and metabolism, 102(7), 2146-2153. https://doi.org/10.1210/jc.2017-00342
Lupoli, Roberta, et al. "Impact of Vitamin D deficiency on subclinical carotid atherosclerosis: a pooled analysis of cohort studies." The Journal of clinical endocrinology and metabolism vol. 102,7 (2017): 2146-2153. doi: https://doi.org/10.1210/jc.2017-00342
Lupoli R, Vaccaro A, Ambrosino P, Poggio P, Amato M, Di Minno MN. Impact of Vitamin D deficiency on subclinical carotid atherosclerosis: a pooled analysis of cohort studies. J Clin Endocrinol Metab. 2017 Jul;102(7):2146-2153. doi: 10.1210/jc.2017-00342. Epub 2017 May 09. PMID: 28609831.
Copy Download .nbib Format: NLM
Downregulation of AdipoR1 is Associated with increased Circulating Adiponectin Levels in Serbian Chronic Kidney Disease Patients.

Journal of medical biochemistry

Sopić M, Joksić J, Spasojević-Kalimanovska V, Bogavac-Stanojević N, Simić-Ogrizović S, Kravljača M, Jelić Ivanović Z.
PMID: 28670196
J Med Biochem. 2016 Nov 02;35(4):436-442. doi: 10.1515/jomb-2016-0007. eCollection 2016 Oct.

BACKGROUND: Since the rise in plasma adiponectin levels in chronic kidney disease (CKD) patients has not yet been elucidated, we sought to investigate if patients on hemodialysis (HD) have altered expression of adiponectin receptors in peripheral blood mononuclear cells...

Cite
Sopić M, Joksić J, Spasojević-Kalimanovska V, et al. Downregulation of AdipoR1 is Associated with increased Circulating Adiponectin Levels in Serbian Chronic Kidney Disease Patients. J Med Biochem. 2016;35(4):436-442doi: 10.1515/jomb-2016-0007.
Sopić, M., Joksić, J., Spasojević-Kalimanovska, V., Bogavac-Stanojević, N., Simić-Ogrizović, S., Kravljača, M., & Jelić Ivanović, Z. (2016). Downregulation of AdipoR1 is Associated with increased Circulating Adiponectin Levels in Serbian Chronic Kidney Disease Patients. Journal of medical biochemistry, 35(4), 436-442. https://doi.org/10.1515/jomb-2016-0007
Sopić, Miron, et al. "Downregulation of AdipoR1 is Associated with increased Circulating Adiponectin Levels in Serbian Chronic Kidney Disease Patients." Journal of medical biochemistry vol. 35,4 (2016): 436-442. doi: https://doi.org/10.1515/jomb-2016-0007
Sopić M, Joksić J, Spasojević-Kalimanovska V, Bogavac-Stanojević N, Simić-Ogrizović S, Kravljača M, Jelić Ivanović Z. Downregulation of AdipoR1 is Associated with increased Circulating Adiponectin Levels in Serbian Chronic Kidney Disease Patients. J Med Biochem. 2016 Nov 02;35(4):436-442. doi: 10.1515/jomb-2016-0007. eCollection 2016 Oct. PMID: 28670196; PMCID: PMC5471639.
Copy Download .nbib Format: NLM
Adverse effects of endocrine therapy in breast cancer: single institute experience.

Contemporary oncology (Poznan, Poland)

Sert F, Ozsaran Z, Esen E, Alanyalı S, Sert I, Haydaoglu A, Aras A.
PMID: 25477758
Contemp Oncol (Pozn). 2014;18(5):344-8. doi: 10.5114/wo.2014.45245. Epub 2014 Nov 05.

AIM OF THE STUDY: The main purpose of this study is to assess the known adverse effects of adjuvant endocrine therapy for non-metastatic breast cancer patients and to present our single center experience with light of literature.MATERIAL AND METHODS:...

Cite
Sert F, Ozsaran Z, Esen E, et al. Adverse effects of endocrine therapy in breast cancer: single institute experience. Contemp Oncol (Pozn). 2014;18(5):344-8doi: 10.5114/wo.2014.45245.
Sert, F., Ozsaran, Z., Esen, E., Alanyalı, S., Sert, I., Haydaoglu, A., & Aras, A. (2014). Adverse effects of endocrine therapy in breast cancer: single institute experience. Contemporary oncology (Poznan, Poland), 18(5), 344-8. https://doi.org/10.5114/wo.2014.45245
Sert, Fatma, et al. "Adverse effects of endocrine therapy in breast cancer: single institute experience." Contemporary oncology (Poznan, Poland) vol. 18,5 (2014): 344-8. doi: https://doi.org/10.5114/wo.2014.45245
Sert F, Ozsaran Z, Esen E, Alanyalı S, Sert I, Haydaoglu A, Aras A. Adverse effects of endocrine therapy in breast cancer: single institute experience. Contemp Oncol (Pozn). 2014;18(5):344-8. doi: 10.5114/wo.2014.45245. Epub 2014 Nov 05. PMID: 25477758; PMCID: PMC4248057.
Copy Download .nbib Format: NLM
High Density Lipoprotein Cholesterol Increasing Therapy: The Unmet Cardiovascular Need.

Translational medicine @ UniSa

Cimmino G, Ciccarelli G, Morello A, Ciccarelli M, Golino P.
PMID: 26535185
Transl Med UniSa. 2014 Sep 01;12:29-40. eCollection 2015.

Despite aggressive strategies are now available to reduce LDL-cholesterol, the risk of cardiovascular events in patients with coronary artery disease remains substantial. Several preclinical and clinical studies have shown that drug therapy ultimately leads to a regression of the...

Cite
Cimmino G, Ciccarelli G, Morello A, et al. High Density Lipoprotein Cholesterol Increasing Therapy: The Unmet Cardiovascular Need. Transl Med UniSa. 2014;12:29-40
Cimmino, G., Ciccarelli, G., Morello, A., Ciccarelli, M., & Golino, P. (2015). High Density Lipoprotein Cholesterol Increasing Therapy: The Unmet Cardiovascular Need. Translational medicine @ UniSa, 1229-40.
Cimmino, Giovanni, et al. "High Density Lipoprotein Cholesterol Increasing Therapy: The Unmet Cardiovascular Need." Translational medicine @ UniSa vol. 12 (2015): 29-40.
Cimmino G, Ciccarelli G, Morello A, Ciccarelli M, Golino P. High Density Lipoprotein Cholesterol Increasing Therapy: The Unmet Cardiovascular Need. Transl Med UniSa. 2014 Sep 01;12:29-40. eCollection 2015. PMID: 26535185; PMCID: PMC4592041.
Copy Download .nbib Format: NLM
Serum prolidase activity is associated with non-diabetic metabolic syndrome.

Diabetology & metabolic syndrome

Tabur S, Oguz E, Eren MA, Korkmaz H, Savas E, Aksoy N, Sabuncu T.
PMID: 25540672
Diabetol Metab Syndr. 2014 Dec 17;6(1):142. doi: 10.1186/1758-5996-6-142. eCollection 2014.

OBJECTIVE: The aim of this study was to determine the role of serum prolidase activity and the possible association with oxidative stress parameters in non-diabetic metabolic syndrome.METHODS: 30 obese patients without metabolic syndrome (MetS), 34 non-diabetic obese patients with...

Cite
Tabur S, Oguz E, Eren MA, et al. Serum prolidase activity is associated with non-diabetic metabolic syndrome. Diabetol Metab Syndr. 2014;6(1):142doi: 10.1186/1758-5996-6-142.
Tabur, S., Oguz, E., Eren, M. A., Korkmaz, H., Savas, E., Aksoy, N., & Sabuncu, T. (2014). Serum prolidase activity is associated with non-diabetic metabolic syndrome. Diabetology & metabolic syndrome, 6(1), 142. https://doi.org/10.1186/1758-5996-6-142
Tabur, Suzan, et al. "Serum prolidase activity is associated with non-diabetic metabolic syndrome." Diabetology & metabolic syndrome vol. 6,1 (2014): 142. doi: https://doi.org/10.1186/1758-5996-6-142
Tabur S, Oguz E, Eren MA, Korkmaz H, Savas E, Aksoy N, Sabuncu T. Serum prolidase activity is associated with non-diabetic metabolic syndrome. Diabetol Metab Syndr. 2014 Dec 17;6(1):142. doi: 10.1186/1758-5996-6-142. eCollection 2014. PMID: 25540672; PMCID: PMC4276100.
Copy Download .nbib Format: NLM
Effects of combined exercise on cardiovascular risk factors and serum BDNF level in mid-aged women.

Journal of exercise nutrition & biochemistry

Cho HC, Kim JK, Lee NJ, Kim SY, Yoon NK.
PMID: 25566440
J Exerc Nutrition Biochem. 2014 Mar;18(1):61-7. doi: 10.5717/jenb.2014.18.1.61. Epub 2014 Feb 21.

PURPOSE: The purposes of this study is first to examine a positive effect of long term combined exercise including aerobic and resistance exercise on increasing level of serum BDNF, and investigate how aerobic exercise is related to improving BDNF...

Cite
Cho HC, Kim JK, Lee NJ, et al. Effects of combined exercise on cardiovascular risk factors and serum BDNF level in mid-aged women. J Exerc Nutrition Biochem. 2014;18(1):61-7doi: 10.5717/jenb.2014.18.1.61.
Cho, H. C., Kim, J. K., Lee, N. J., Kim, S. Y., & Yoon, N. K. (2014). Effects of combined exercise on cardiovascular risk factors and serum BDNF level in mid-aged women. Journal of exercise nutrition & biochemistry, 18(1), 61-7. https://doi.org/10.5717/jenb.2014.18.1.61
Cho, Hyun Chul, et al. "Effects of combined exercise on cardiovascular risk factors and serum BDNF level in mid-aged women." Journal of exercise nutrition & biochemistry vol. 18,1 (2014): 61-7. doi: https://doi.org/10.5717/jenb.2014.18.1.61
Cho HC, Kim JK, Lee NJ, Kim SY, Yoon NK. Effects of combined exercise on cardiovascular risk factors and serum BDNF level in mid-aged women. J Exerc Nutrition Biochem. 2014 Mar;18(1):61-7. doi: 10.5717/jenb.2014.18.1.61. Epub 2014 Feb 21. PMID: 25566440; PMCID: PMC4241931.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 2105 entries